Tempus AI reinstated with a Buy at TD Cowen
TD Cowen analyst Dan Brennan reinstated coverage of Tempus AI (TEM) with a Buy rating and price target of $74, up from $58, following the ...
Nasdaq15d
Tempus AI: A Game-Changer in AI-Powered Healthcare
The more significant driver of Tempus’ rally was the announcement of its new AI-enabled health app, Olivia. Designed as a personal health concierge, Olivia integrates patient data from over ...